Skip to Main Content

David Geffen School of Medicine at UCLA (DGSOM): Seed Grant Program

The information below is from the 2021 request for proposals. Please see the opportunity website for updated information. 

This program represents a collaboration between the School of Medicine, the Clinical and Translational Science Institute (CTSI), the DGSOM Research Themes and the Institute of Precision Health (IPH). The goal of the program is to promote the assembly of teams of scientists that are well-positioned to perform innovative, high-impact research and ultimately compete for large team science grants from federal agencies and private foundations.

Applications are encouraged from faculty throughout the UCLA campus in any biomedical or medical research area in which groundbreaking advances catalyzed by teams of researchers can be envisioned. Applications that take advantage of the infrastructures established by the IPH and CTSI are especially encouraged, as are applications that span disciplines or span the basic, translational, clinical, and community spectrum.

One important aspect of the 2021 program is that they would like to encourage compelling projects relevant to their newest Theme in Health Equity and Translational Social Science, as well as projects that span two or more of their Research Themes; faculty discussions of potential cross-Theme projects may lead to efforts in new areas in which an investigator team may have the potential for an unusually large impact.

The application process includes two phases:

  • Phase I: a small planning grant (required)
  • Phase II: full grant application (limited to PIs who submitted and obtained Planning Grants). 

See Application Homepage for more details about the two phases.

 

Go to Application Homepage

Award Amount and Details

Award Amount
$250,000
Award Details

Phase I (Small Planning Grants): Successful applicants will be permitted to spend up to $1,000. 

Phase II (Full grant applications): Full grant applicants may request up to $250,000 in direct costs.  

Deadlines and Date Information

Due Date
2021-07-15

The due dates listed below are the most recent due dates our office is aware of. Please see the opportunity home page for information about potential upcoming deadlines or other opportunities.

Important Dates 

  • July 15, 2021 - Planning Grant Applications Due by 11:59pm (Required) 
  • August 16, 2021 - Planning Grant Decisions Announced 
  • November 15, 2021 - Full Grant Applications Due (Restricted to Planning Grant Recipients)
  • December 20, 2021 - Final Decisions Announced (Tentative)
  • January 3, 2022 - Earliest Funding Date 

 

Eligibility Information

Who's Eligible
Academic appointees
Members of the Academic Senate
Other
Eligibility Details
  • The Lead PI for both a Planning Grant application and a Full Grant Application must be a UCLA faculty member in the Regular Professor, In-Residence Professor, Clinical X Professor, or Health Sciences Clinical Professor series, or a fully independent investigator in the Adjunct Professor or Researcher Series.
  • The Lead PI on each application must hold a primary appointment on the UCLA campus, in that her or his extramural grant applications must typically be submitted through the UCLA Office of Contract and Grant Administration. An exception to this policy will be made for applications relevant to the Health Equity and Translational Social Science Research Theme; in these research areas, faculty with primary appointments at Olive View-UCLA Medical Center, Harbor-UCLA Medical Center, West Los Angeles VA Medical Center, and Charles R. Drew University of Medicine and Science are permitted to apply.
  • Each faculty member may serve as Lead PI on only one Planning Grant application.
  • Faculty who identify with a group historically underrepresented in science and medicine are strongly encouraged to apply.
  • Full Grant applications can be submitted only by Lead PIs awarded a Planning Grant.
  • A faculty member may serve as a Co-PI or Co-Investigator (but not Lead PI) on more than one Planning Grant application and more than one Full Grant Application, although excessive commitment could be detrimental during the review process.
  • All investigator teams are required to include at least one promising Assistant Professor in an impactful position as a co-PI or highly significant co-investigator.
  • Faculty in the Adjunct and Research series can serve as Co-PIs or Co-Investigators (but not Lead PIs unless fully independent) on Planning Grant applications and Full Grant applications.
  • Faculty at CTSI partner institutions can serve as Co-PIs or Co-Investigators (but not Lead PIs) on Planning Grant applications and Full Grant applications, except in areas relevant to the Health Equity and Translational Social Science Theme, as specified above.
  • Faculty will be asked to indicate which of the seven Research Themes are relevant to the application, and may select Precision Health as a strategic priority that is highly relevant to application. Alternatively, the applicant may select “Not Relevant to a Research Theme.” This information will be used to identify appropriate reviewers, but applications on all topics will be given full consideration by a diverse group of reviewers from the Research Themes and IPH, and with additional expertise included on the review panels as needed.
  • The PI of each funded award must submit a six-month progress report and final annual report. 
Information Source
Information identified by Office of Research & Creative Activities staff

Administering Unit
David Geffen School of Medicine at UCLA (DGSOM)
Funding Type
Research
Changed
July 28, 2021
Important Note These opportunities have been collated for the benefit of the campus community, but in all cases viewers should refer to the pages of the hosting unit for the most current/accurate information.